HomeHealth articlesc1q nephropathyWhat Is C1q Nephropathy?

C1q Nephropathy - Causes, Symptoms, and Treatment

Verified dataVerified data
0

4 min read

Share

C1q nephropathy is a rare kidney disease that causes protein excretion in the urine. The article below discusses this condition in detail.

Medically reviewed by

Dr. Yash Kathuria

Published At April 18, 2023
Reviewed AtApril 18, 2023

What Is C1q Nephropathy?

C1q nephropathy is a kidney disorder in which large amounts of protein are lost in the urine. It is one of the many disorders that can lead to nephrotic syndrome. C1q is a normal immune system protein and can be found in the blood circulation of most healthy people. However, in C1q nephropathy, this protein can also be found deposited throughout the kidneys. Since these deposits can only be viewed under a microscope, a kidney biopsy is required for the diagnosis of C1q nephropathy.

The kidneys typically clean the blood of the natural waste products that get accumulated over time. To do this, the kidneys must filter all the blood in the body many times daily. That is, in fact, what urine is, filtered blood. Usually, this blood gets filtered by the kidney without losing any proteins that are supposed to remain in circulation. However, when the kidney filters get damaged, protein sometimes slips through and enters the urine. This condition is called proteinuria.

Being one of the more recently discovered kidney diseases, doctors are still trying to figure out exactly how to describe C1q nephropathy and treat it.

How Does C1q Nephropathy Look?

Here is a quick overview of the kidney- there are two kidneys, located one on each side of the lower back. All the blood in the body passes through the kidneys several times throughout the day, and every time the blood goes through, some of it gets filtered by the glomeruli of the kidney (singular is glomerulus). This filtering is the procedure in which the body cleans the blood, removes excess water, and some filtered blood becomes urine. The color of the urine is not red like blood. This is because the red blood cells (RBC), which give blood its color, are too large to pass through the filters. A glomerulus is made of a tiny bag of blood vessels through which blood filtration occurs, and all of the filtered-out blood (urine) moves into tubes (ureters) that eventually lead to the bladder.

In C1q nephropathy, the kidney filters can look normal under a standard microscope (although they may also have visibly scarred areas). The differences can only be seen when the special stains that are specific to the C1q protein are added to the sample. The areas where C1q deposits, these stains cause those areas of the biopsy to glow bright green under certain types of light. In addition, if the biopsy is evaluated in an electron microscope (which has the capacity to magnify an object over a million times), those C1q deposits themselves can be seen.

What Are the Causes of C1q Nephropathy?

It is still unknown why C1q nephropathy develops or why some people get C1q deposited in their kidneys while most do not. The deposited C1q seems to activate the immune system within the kidney itself. This resulting immune response and inflammation cause kidney damage. Similar to minimal change disease (kidney disorder with damage to glomeruli causing loss of protein in urine), C1q nephropathy is more common in childhood.

What Are the Symptoms of C1q Nephropathy?

The symptom of C1q nephropathy, which is the most noticeable, is often edema, or swelling, which can be profound. The swelling typically starts in the feet and legs but can also move into the hips and abdomen. Other symptoms include-

  • High blood pressure.

  • Increased cholesterol levels.

  • A tendency to form blood clots.

A urine sample can measure protein levels, and a blood test can calculate kidney function, or it can be measured directly by adding a 24-hour urine collection. C1q nephropathy can cause only proteinuria or proteinuria and renal failure together, so a doctor must assess both. C1q nephropathy often leads to nephrotic syndrome.

When someone excretes an excess of protein in their urine, they can often develop a condition called nephrotic syndrome. The symptoms of this syndrome always include-

  • More than three grams of protein in the urine per day (proteinuria).

  • Peripheral edema (swelling).

  • Hypoalbuminemia (less protein in the blood than usual).

  • Hyperlipidemia (high cholesterol).

  • Hypercoagulability (increased tendency to form blood clots).

How Is C1q Nephropathy Diagnosed?

C1q Nephropathy is a relatively recently discovered disease. It has been discovered with the help of a specialized electron microscope and immunofluorescence microscope that contains stains specific for the deposits of the C1q protein. Therefore, a kidney biopsy is required to diagnose C1q nephropathy.

What Is the Treatment for C1q Nephropathy?

The treatment for C1q nephropathy is generally the same as for nephrotic syndrome. It is essential to consult a kidney specialist regularly for the monitoring of kidney function, the severity of proteinuria, cholesterol, and blood pressure.

The most commonly used drug for the treatment of C1q nephropathy is steroids. However, several different types of immunosuppressants, or medications that suppress the immune system, can also be considered.

If these do not prove effective, it is essential to be on a drug that reduces the amount of protein in the urine. These medications are ACE inhibitors (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers).

A nephrologist may also recommend the following-

  • Diuretics for the elimination of excess fluids in the body.

  • Anticoagulants to prevent blood clots.

  • Low sodium diet to help control edema (swelling).

  • Statins to lower cholesterol levels.

  • Blood pressure medications to lower high blood pressure.

  • Maintaining a healthy diet is important. Appropriate quantity of protein and fluid intake according to the recommendations of the nephrologists. A healthy diet consists of low salt intake with an emphasis on fruits and vegetables and is low in saturated fat and cholesterol.

  • Exercising.

  • Quit smoking.

  • Vitamins.

Conclusion:

Since it is both a relatively new and rare disease, it is pretty challenging to predict the course of C1q nephropathy. While some people have been observed to go into complete remission, a few others have developed an end-stage renal disease that may require dialysis or a kidney transplant. Fortunately, so far, complete renal failure seems to be the exception rather than the rule. The kidney biopsy can also help predict the course of the disease.

Frequently Asked Questions

1.

How Do You Handle C1q Nephropathy?

C1q Nephropathy is a difficult condition to treat, and anyone suffering from it should see a renal expert frequently. Taking a prescription that lowers the quantity of protein in the urine is critical. ACE inhibitors these drugs are known as ACE inhibitors (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers).

2.

What Is the Outlook on C1q Nephropathy?

A rare glomerular illness known as C1q nephropathy is characterized by mesangial C1q deposits that may be seen using immunofluorescence microscopy. Most patients with C1q nephropathy had positive prognoses during their three to fifteen-year follow-up.

3.

What Is the Prevalence of C1q Nephropathy?

C1q nephropathy is uncommon, with incidence ranging from 0.2 to 2.5 % in pediatric and adult biopsies and 2.1 to 9.2 % in pediatric biopsies. There is a modest male predominance of 68 %. It primarily affects older children and adolescents.

4.

What Is the Most Recent Nephropathy Treatment?

To lessen the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease (CKD), the U.S. Food and Drug Administration (FDA) approved empagliflozin tablets.

5.

How Can Nephropathy Be Prevented?

To lower the likelihood of getting nephropathy:


- Schedule regular check-ups to control diabetes.


- Have diabetes treatment.


- Control hypertension and other health issues.


- Sustain an appropriate weight.


- Avoid smoking.

6.

Is There a Treatment for Nephropathy?

Nephropathy has no known treatment, although medications can delay the condition's progression. Certain individuals require medical intervention to decrease inflammation, minimize protein leakage into the urine, and avert renal failure. These therapies could aid the disease's "remission," or cessation of active symptoms.

7.

What Is the Clinical Manifestation of a C1q Complement System Mutation?

When one of the C1q genes is mutated, the resultant product is either low-molecular-weight (LMW) C1q or a total deficit with low C1q levels. SLE (systemic lupus erythematosus) is the most common clinical presentation of C1q deficiency. Of all complement abnormalities, people with C1q deficiency have the highest chance of developing SLE (>90% prevalence).

8.

What Drug Is Used to Treat Protein-Losing Nephropathy?

Benazepril and Enalapril are the two drugs most frequently utilized to treat protein-losing nephropathy. In individuals with diabetes and nondiabetic renal disease associated with proteinuria, ACE (angiotensin-converting enzyme) inhibitors decrease both the rate of proteinuria and the rate at which renal function deteriorates.

9.

How Does C1q Become Active?

A protein complex called complement component 1q, or simply C1q, is a component of the innate immune system's complement system. C1q, C1r, and C1s all constitute the C1 complex. The adaptive immune system's antibodies can bind antigens, creating an antigen-antibody complex. The activation of the C1 complex occurs when C1q binds antigen-antibody complexes. The complement system's classical complement pathway is started when the C1 complex is activated.

10.

For C1q Nephropathy, What Is the Survival Rate?

The progression of C1q nephropathy is unpredictable because it is a relatively rare and new condition. While total recovery has been found to occur in certain cases, end-stage renal disease has developed in others, necessitating dialysis or kidney transplantation.


In patients with C1q nephropathy, the average kidney survival was 81.0 months.

11.

What Is Recognized by C1q Nephropathy?

A kidney condition known as C1q nephropathy causes significant protein loss in the urine. It is among the numerous illnesses that might result in nephrotic syndrome. Most healthy individuals have some amount of the immune system's typical protein, C1q, circulating in their blood.

12.

What Cells Make C1q?

The main cells synthesizing the C1q molecule are myeloid cells, such as dendritic cells, macrophages, and monocytes. However, other cells like fibroblasts, glial cells, mast cells, trophoblasts, endothelial cells, and epithelial cells also synthesize it.

13.

What Are the Early Symptoms of C1q Nephropathy?

The most obvious sign of C1q nephropathy is frequent swelling or edema, which can be quite severe. Although it can sometimes spread to the hips and abdomen, this usually begins in the legs and feet. Additional signs include a propensity to produce blood clots, elevated blood pressure, and elevated cholesterol.

Dr. Yash Kathuria
Dr. Yash Kathuria

Family Physician

Tags:

c1q nephropathy
Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Source Article ArrowMost popular articles

Do you have a question on

c1q nephropathy

Ask a doctor online

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy